Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Former Accuri CEO to lead intravenous device start-up

This article was originally published in Clinica

Executive Summary

Tangent Medical Technologies, a development-stage company focused on next-generation intravenous access systems, has appointed Jeffrey Williams as CEO and chairman. Mr Williams was formerly president and CEO of flow cytometry specialist Accuri Cytometers until the company was sold to Becton Dickinson in March (www.clinica.co.uk, 21 March 2011). Prior to that, he was head of molecular diagnostic company HandyLab. Mr Williams succeeds Hank Brown, who was a founding investor of Ann Arbor, Michigan-based Tangent and has been leading the company since it was founded in July 2009. Tangent's lead product is the NovaCath peripheral IV system with integrated stablisation and blood containment features; the company expects to begin generating revenue from sales of the product in 2012.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT097785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel